SHR-1681

· Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR-1681, covering 2026-01-09 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]